text:
Q: After the verb "will", we must use another simple verb
I'll meet you in the city, that is, I will if the trains are running.

I am wondering why after will, there is no verb.

A: The verb is omitted to avoid repetition. Here's what you'd say if you included it:

I'll meet you in the city--that is, I'll meet you in the city if the trains are running.

Most people feel that such a repetition is clumsy and unnecessary.
You couldn't just say:

I'll meet you in the city--that is, I'll meet if the trains are running.

because meet demands an object. You could just omit repeating the city, though, on the same principle as omitting the whole verb phrase:

I'll meet you in the city--that is, I'll meet you if the trains are running.

Note that when omitting all of the verb phrase except will, you can't use a contraction:

I'll meet you in the city--that is, I'll if the trains are running.

The word will has to hold the place of the entire verb phrase, so it's stressed and can't be shortened even further into a contraction.

A: One of the main properties of auxiliary verbs is that they can exhibit code (show code). What this means is that we can use just the auxiliary verb to represent the whole of the rest of the verb phrase. The listener must be able to tell what this missing information is. Usually it has already been talked about, but it might be clear from the physical situation.
There are two main groups of auxiliary verbs. The first includes BE, HAVE and the dummy auxiliary DO. The second group, known as modal verbs has nine central members (depending on how you count them). These are:

*

*CAN, COULD, MAY, MIGHT, SHALL, SHOULD, WILL, WOULD and MUST
If there is more than one auxiliary in a verb phrase, then we can choose which auxiliary we want to exhibit code. Look at the following example:
A. Has your elephant been eating my plants?
B. She might have been eating your plants.
Here speaker B's answer is very long. We don't need to use the whole phrase "might have been eating your plants", because speaker A will be able to understand what we are talking about. There are three auxiliary verbs in B's reply. We can use any of them to take code for the rest of the sentence:

*

*She might have been. [  eating your plants ]

*She might have. [  been eating your plants ]

*She might. [  have been eating your plants ]

The Original Poster's Question

I'll meet you in the city. That is, I will if the trains are running.

The reason that there is no verb after will in the second sentence is that WILL is exhibiting code for "will meet you in the city". The speaker can do this because we can understand meet you in the city from the previous sentence. The reason that WILL is allowed to do this is that it is an auxiliary verb.
Hope this is helpful!


This popular science book is part memoir and part examination of narcolepsy and other sleep disorders. Nicholls himself has narcolepsy, and he examines a variety of sleep disorders, especially sleep apnea. He says that, unexpectedly, writing this book helped him dramatically improve his own sleep problems. In the process of research, he found that he also had catalepsy, which means he is prone to seizures that include a loss of sensation and rigidity of the body. It turns out that narcolepsy and catalepsy are frequently associated with each other.
Nicholls is a talented writer who combines personal stories and anecdotes from science with an examination of classic work in sleep science and recent research. While there are many books on the importance of sleep and with theories about how to sleep well, they tend to be rather similar. Sleepyhead is distinctive in addressing scientific studies and issues that don't get included in the more standard fare. It covers neuroscience, genetics, brain studies, and many clinical case studies. So this book will provide information that will be new to readers even if they have read other books on sleep.
Not all topics get equal treatment. Nicholls dismisses the interpretation of dreams in 2 pages, citing evidence that dreaming is more likely a side effect of REM activity, and probably does not itself perform any important functions. He allows that dreams may be meaningful but does not put much store in the process of trying to interpret them. But Nicholls does take an open minded approach to understanding the spectrum of states below full consciousness and to the treatment of sleep disorders. He even cites evidence that practicing with a didgeridoo for half an hour a day can be effective in treating sleep apnea.
So Sleepyhead is an engaging book full of facts and good stories. It gives a complex view of sleep disorders and the science of sleep. Recommended.
The unabridged audiobook performed by Henry Drury is performed with energy. It does not have the endnotes, but is a good way of consuming the book.


The six arrows pointing out PowerPoint template and keynote is a slide with a black background containing a pentagon shape with arrows pointing out from all side along with three icons of people inside the pentagon. There are six arrows in green, blue, grey, orange, pink and red color point out to a small round of the same color, and nearby to each circle, there is a small text box to write a brief description on what you are presenting to the audience. The Six Arrows Template can be used for expressing your business concepts, company brands, business classifications, products, budget flow, consumer buying attitude etc. The slide is fresh and easy to understand for the audience while in the meeting. The template is designed in both PowerPoint and keynote in both the aspect ratio 4:3(Normal) and 16:9 (widescreen).
Arrow PowerPoint template is ideal for business presentations or strategy presentations where distinct models can be explained. The arrow diagram PowerPoint is most suitable for the presentation related to product features and the descriptions. Users can put the product or brand in the center and outline its specifications through the outward pointing arrows. For example, if the product is a newly launched smartphone, presenters can attach the image in the center zone and give its detailed specifications to the audience.
Arrow PowerPoint diagram that shows the six elements of a process or phenomenon contain six infographic icons on the arrow points. These icons are; gearbox, tools, the hand with books, steps, paper with pencil and stacked coins. Users can take the support of these icons and deliver the theme which shows relative proximity with the presentation topic. Alternatively, users can use this space to write sub-element of the concept. The six arrows pointing out template for PowerPoint allows 100% customization of the features. Presenters can change the color or the diagram, or people icon that shows in the center zone. Users can download colorful and attractive arrow PowerPoint diagrams from our gallery and present business process flow or steps.
You can access more Arrow PowerPoint Templates here Grab the free ppt now!


70% of the beers are from Colorado brewers, while the other 30% are out-of-state crafts. You could say they're COhabitating, lol.
Every last bottle of liqueur and vino is from in-state distilleries and wineries.
Expect to see bottles/ cans from big guys like Oskar Blues & Left Hand, up-and-comers like Ska Brewing and Crazy Mountain, and total noobs like Renegade Brewing, who just recently began canning.
2 Rivers leads the local wine cull, while hard booze counts everything from Stranahan's, to Leopold Bros, Dancing Pines, and 291 Distillery's aged whiskeys, previously not available in Denver.
Even the mixers are local, like margarita/ mojito/ jalapeno bloody mary bases from Top Shelf, also where a hilarious bartender would ironically keep his Rumple Minze in jest.


Good to hear Hack. That is my intention too except my goals are crazier yet. Perhaps we could have a joint venture if our ideas align.
A little update on project status: pif rom is executed, and rom boot code too. I am currently working on pi dma.
It may seem very basic but it is quite long to do it the way i'm doing it: the 5 stage pipeline of the r4300 is emulated with some of the subtle details like register bypassing between stages, and all the interlocks and exceptions. It emulates the instruction and data caches as well as the write buffer. I am even trying to measure the cop0 hazards mentioned in the processor user guide. I have tried to measure all timing for peripheral I/O (that is why simple stuff like pi dma can take a long time to implement because i have a lot of measurement to do on real hardware.
That's awesome to hear hack best of luck with it all!
Make sure the RSP is emulated AT LEAST with cycle accuracy.
Don't even bother if its anything less.
Great to hear! I can't wait to see whats next!
Will this be cross-platform? I hope there are plans to at least make it portable. Would be sweet.
Can't wait to see something!


Sodium tripolyphosphate drying equipment_sodium tripolyphosphate drying machine - Changzhou YI DU Drying Equipment Co., Ltd.
The molecular formula of sodium tripolyphosphate is Na5P3O10,formula weight is about 367.86,Solubility OF Na5P3O10·6H2O is 13g/100g.Because of the five Na Yuanzi,so we called it as 5NA.The effect of sodium tripolyphosphate:Mainly in the washing industry,it is common detergent additive.In addition,sodium tripolyphosphate can be used widely in the industry of petroleum, metallurgy, mining, paper, water treatment and so on.It had difference between industry grade and food grade.
It can be producted by neutralization reaction between phosphoric acid and sodium carbonate,and then through condensation.In the process of preparing phosphoric acid,it can be divided into wet and hot method.Wet process link more,and the contant is lower,it as the wet drying with the mainly.The yellow phosphorus combustion made from phosphoric acid.Common thermal process technology:Converter one step method、Spray dryers,Polymerization two step method and air column method.
1 Converter one step method:The whole process is about how to made sodium dihydrogen tripolyphosphate.and the liquid through the nozzle into the furnace(about 200℃) and hot air contact, evaporation.The neutralized solution obtained after water evaporation of sodium dihydrogen phosphate,in high temperature environment it can be polycondensated.
2 Spray dryer and Polymerization two step method:Whole process of drying will through two steps:Drying and polymerization,and the temp will be control very low.The common method is spray dryers.
3 One-step method:The method was first proposed in foreign countries,In the last century enter into China about the 80's.The method is also based on spray dryer,The whole drying polymerization is just one step.But there are second ways to do it,this method requires a higher energy consumption, although the method does not need to be aggregated,the entire control is more complex, higher equipment investment.
We can get the conclusion through the above pictures,one return converter is added in the process of drying equipment and the above one step process.Mainly to the tail gas into a heat source,And spray drying of powder in the tail gas..After measurement we found,we can reduce the temperature from 420℃ to 150℃,Reduction of energy consumption about 30%.
1Different material returning device is used,quality has been effectively controlled,product quality level can be adjusted by the user.And meet different requirement of production.After testing,we find that the quality of the material is significantly improved compared with the three methods mentioned above,and it is stable.
2 The whole structure of the material makes the residence time of the material in the dryer.This allows the polymerization to be completed at a lower temperature.
3 After production and energy consumption calculation,we found that the new type of sodium phosphate and sodium phosphate drying machine has the advantages of lower energy consumption and higher output.


mmmmmmmm James Business 2012 Photo - © Copyright Megan Chromik and licensed for reuse under this Creative Commons Licence.
i dont think the human race will eva bee readee four diss juan..
This is really nice. Makes me want to overlook some scenery and contemplate.
@downeydarko: yo my bad dude taking forever to get back to ya, just been busy these past cpl days... yea thats coo tho, feel free man... lemme know when you finish, would love to hear what you do w/ it.
yo is it cool to record on these beats? all credit on the production where its due obviously!
@wastersp: haha this is why I love soundcloud... I can't tell you how many times I say that to myself everyday when I'm listening to other cats stuff... so much talent around here, thank you so much tho... means alot man!
goddamn i love this for real... so chill. can't even describe the feeling it portrays. you got some serious talent man. your style is toooo dope.


CEEC has been working with women and MCAs from Kandara Sub County in Murang'a County on a Women and Devolved Governance Project supported by GIZ (CPS) which aims at promoting women's participation in devolved governance. In February and March respectively the women and the MCAs were trained on devolved governance, transformative leadership and women's participation in governance. After the trainings the women mobilized other women from their respective wards namely Kagundu-ini, Gaichanjiru, Muruka, Nga'raria, Ruchu and Ithiru to attend ward based forums. The purpose of the forums was to help the women address their issues of concern to their leaders. All the six MCAs attended the forums in their respective wards and responded to the concerns raised by the women. The women were very happy with the forums especially given that some of them did not know their MCAs and those who do had never seen them after they voted for them. They felt the forums had opened up channels of communication between them and their leaders and they would now be able to continue engaging with them. The MCAs on the other hand appreciated the fact that the forums had provided them with an opportunity to engage with a big segment of their constituents. They affirmed the important role that women play and pledged to work with them to ensure that there was gender inclusive governance in their respective wards.


Mentor Walk College Immersion day was hosted at Agnes Scott College On Oct 25, 2013. This is an innovative initiative of C2P for college preparatory experience for middle and high school students (in this case girls) which inspires children to stay in school and experience a college campus with college students as near peer role models and mentors for the day.
This event was partnered with the United Nations 2nd annual celebration of the International Day of the Girl Child with a theme of "Innovating for Girls' Education." at ASC. One hundred and forty girls from schools including Drew Charter School, Freedom Middle School, the Fugees Academy, Global Village School and Renfroe Middle School participated with ASC student volunteers and faculty who spent the day encouraging girls to finish school and attend college.
Getting ready for the walk and campus tour.
President Kiss passing soccer balls to the girls.


Following the passing of Jane Sallis 16th August 2018, it is with deep regret that we announce Firebird Theatre productions have ceased. The group's legacy is here for all to peruse; the history of the group, the performers, credits for those who worked tirelessly behind the scenes, the performances they took all over the country, and some of the many testimonials received. Further announcements, and news about an Archive Project being undertaken to further pay tribute to all the performers over the years, will follow.
For now, contact should be limited to post which can be forwarded to the appropriate addressee, so apologies for the lack of prompt communication! We hope you understand.


text:
The Mayday Fund Announces 2013-14 Winners of the Mayday Pain & Society Fellowship
New York College of Dentistry's Brian L. Schmidt, DDS, MD, PhD named Mayday Pain & Society Fellow
The Mayday Fund today announced the selection of six experts in pain management to be Fellows of The Mayday Pain & Society Fellowship, including Brian L. Schmidt, DDS, MD, PhD, Director of the Bluestone Center for Clinical Research and NYU Oral Cancer Center at the New York University College of Dentistry. The new Fellows come from across the United States and Canada, specializing in a wide range of health care disciplines, including neuroscience, primary care, physical and rehabilitation medicine, patient advocacy, and pain policy. The Fellowship program is in its ninth year, and will continue for one more session in 2014.
The Fellowship provides pain care leaders with skills to advocate for effective pain management. Fellows learn how to better communicate with the media, policymakers and others to raise visibility for their issues.
"The applicant pool was one of the largest and most impressive to date," said Russell K. Portenoy, MD, Chairman of The Mayday Fellowship Advisory Committee, which selects the Fellows each year. "The response showed us that researchers, clinicians and advocates are becoming increasingly aware of the need for effective communication about the urgent problem of undertreated pain. We are confident that this year's Fellows will bring fresh energy and focus to our program, and will acquire the skills they need to more effectively promote the legitimate needs of patients with pain. More than ever, the patient's voice must be part of the public and professional discourse about pain-related policy and practice," added Portenoy, who is also Chairman of the Department of Pain Medicine and Palliative Care at Beth Israel Medical Center.
The Fellows will develop skills to advocate and communicate on many of the issues they deal with everyday, including the under-treatment of pain, pain research and treatment, pain education, and policies to improve pain care.
"The Mayday Fund Trustees congratulate and welcome this new class of Fellows," said Christina M. Spellman, Executive Director of The Mayday Fund. "We are eager to support such qualified leaders to speak publicly about cutting-edge pain research, education programs, and policy issues impacting pain care."
The new 2013-2014 Fellows are:
· Karen D. Davis, PhD, Head & Senior Scientist, Division of Brain, Imaging and Behaviour – Systems Neuroscience, Toronto Western Research Institute; and Professor, Department of Surgery and Institute of Medical Science, University of Toronto
· Bill McCarberg, MD, Adjunct Assistant Clinical Professor, University of California San Diego; Family Medicine Provider, Neighborhood Healthcare; Hospice Provider, Elizabeth Hospice in Escondido, California
· Brian L. Schmidt, DDS, MD, PhD, Director, Bluestone Center for Clinical Research; Director, New York University Oral Cancer Center; Professor, Department of Oral and Maxillofacial Surgery; Professor, Department of Physiology and Neuroscience; and Co-Leader, Epidemiology and Cancer Control, New York University Cancer Institute
· Steven P. Stanos, DO, Director, Corporate Pain Services, Rehabilitation Institute of Chicago (RIC); Attending Physician, RIC Center for Pain Management; Associate Professor, Department of Physical Medicine and Rehabilitation; Assistant Program Director, Multidisciplinary Pain Fellowship; Department of Anesthesia, Northwestern University Feinberg School of Medicine
· Cindy Steinberg, National Director of Policy and Advocacy, U.S. Pain Foundation
· Catherine Underwood, MBA, CAE, Chief Executive Officer, American Pain Society
As part of their training, the new Fellows will attend an intensive four-day workshop in Washington, DC in October 2013, and will work closely with media and policy coaches from Burness Communications, a public relations firm that works with non-profit organizations, primarily in health and science. Fellows will learn how to connect with local and national media, write opinion editorials, and educate Members of Congress and other policymakers about pain care research and treatment. By improving their communications skills, they will be poised to move the field forward by educating and working with the media, policymakers, advocates, health and business leaders, and their own peers.
The Fellowship Advisory Committee selects six winners each year. On the Advisory Committee for the Mayday Pain & Society Fellowship, in addition to Chair Russell K. Portenoy, MD are: James N. Campbell, MD, Professor Emeritus of Neurosurgery, Johns Hopkins University, CEO of Arcion Therapeutics, Inc., and Executive-in-Residence at InterWest Partners; Scott M. Fishman, MD, Chief, Division of Pain Medicine in the Department of Anesthesiology and Pain Medicine and Professor of Anesthesiology, University of California, Davis; Kathleen M. Foley, MD, Medical Director of the International Palliative Care Initiative of the Public Health Program, Open Society Institute and Attending Neurologist in the Department of Neurology, Memorial Sloan-Kettering Cancer Center; Carmen R. Green, MD, Associate Vice President and Associate Dean for Health Equity and Inclusion and Professor of Anesthesiology, Obstetrics & Gynecology, and Health Management & Policy, University of Michigan Health System; Sandra H. Johnson, JD, Professor Emerita of Law and Health Care Ethics, Saint Louis University School of Law; Patrick John McGrath, PhD, Canada Research Chair, Integrated Vice President and Professor of Psychology, Pediatrics and Psychiatry, IWK Health Centre and Capital District Health Authority in Halifax, Canada; and Lonnie Zeltzer, MD, Director of Pediatric Pain Program and Distinguished Professor of Pediatrics, Anesthesiology, Psychiatry and Biobehavioral Sciences, University of California, Los Angeles.
About The Mayday Fund-- Established in 1992, The Mayday Fund is dedicated to further Shirley Steinman Katzenbach's commitment to social and medical causes. Her special interest in the treatment of pain forms the core of the Fund's mission. Over the last 20 years, Mayday has contributed to many different projects, among them, surveys of public attitudes to pain and its treatment; clinical and academic research; assistance to public and professional advocacy groups; the worldwide documentary film, "Life Before Death," which raises awareness about the global crisis of untreated and undertreated pain; and most recently, a video to help health care professionals understand the importance of good communication and treatment for pain and palliative care. For more information on the Fellowship and previous Fellows, visit www.maydayfellows.org. For more information, contact: Dionne Dougall-Bass, 301-961-5803, dionne@burnesscommunications.com, Nick Seaver, 301-280-5727, nseaver@burnesscommunications.com
About the Bluestone Center for Clinical Research-- The Bluestone Center for Clinical Research, in conjunction with the NYU Oral Cancer Center, is an academic research organization located at the NYU College of Dentistry. Bluestone's mission is to take a creative scientific approach to transform world health. Bluestone is dedicated to conducting research in oral cancer, cancer symptomology, pharmaceuticals, medical devices, emerging biotechnology, periodontics, implants, and oral health products. For more information, contact: Andrea Flynn, AndreaN.Flynn@nyu.edu, 212-998-9892.
About the NYU Oral Cancer Center--The NYU Oral Cancer Center provides patients with the latest diagnostic techniques for screening, prevention, treatment and therapy and engages in pioneering research that is changing medicine. For more information, contact: Andrea Flynn, AndreaN.Flynn@nyu.edu, 212-998-9892.

redpajama_set_name: RedPajamaCommonCrawl


Animal models are essential tools for evaluating the therapeutic effects of anticancer drug candidates in preclinical studies and investigating the mechanism of tumor development in basic cancer research. However, the current techniques used to assess tumor growth in these models are unwieldy due to animal maintenance and tumor measurement limitations. Therefore, alternative approaches that are both noninvasive and accurate are needed. Here, we will review the current models and techniques used in cancer research and we will discuss the use of bioluminescence imaging for the precise histological measurement of tumors.
Orthotopic animal models are also commonly used in cancer research as they recapitulate many of the essential, clinically relevant features of tumor growth. Here, cancer cells are inoculated into the equivalent organ from which the cancer originated.1 After inoculation, tumor growth is traditionally assessed by sacrificing groups of experimental animals at different time points and comparing tumor size. Because of the large number of animals and laborious efforts required, the use of orthotopic models is less efficient and more costly than subcutaneous xenograft models.
Bioluminescence imaging techniques enable reliable and sensitive real-time imaging of small tumor lesions.
The mechanism of BLI is based on light-generating enzymes such as firefly luciferase. In this ATP-dependent reaction, luciferase catalyzes the substrate luciferin into the light-emitting product oxyluciferin.4,5 While many invertebrates, bacteria, and protists express luciferase, isoforms of this enzyme are not harbored in mammalian genomes; therefore, the first step in generating BLI models is to establish reporter-labeled cancer cell lines that stably express the luciferase protein. The luciferase-reporter cancer cells are then inoculated into experimental animals and bioluminescence measurements are assessed via in vivo imaging equipment after the administration of luciferin. Although the use of BLI in cancer research has increased substantially in recent years, there is a limited number of credible, commercially available luciferase-reporter cancer cell lines that can be used to create BLI animal models.
To support this need, ATCC has created a portfolio of well-authenticated reporter cell lines that express high levels of firefly luciferase. Here, a set of commonly used human or mouse tumor cell lines representing different tissue types were selected for genetic engineering on the basis of their scientific relevance and their capacity for establishing tumors in animals. As luciferase expression level and stability are the key considerations for a successful BLI model, ATCC used lentivirus transfection and single cell cloning approaches to isolate stable clones with high luciferase expression. The luciferase-expressing cell lines were authenticated at the phenotypic, genomic, and functional levels; here, cell lines were extensively characterized via cell morphology examination, growth kinetics studies, STR profiling, mouse pathogen testing, bioluminescence signal quantification, and in vivo live animal BLI analysis. Overall, these luciferase-expressing reporter cell lines provide cancer researchers with a complete set of reliable, easy-to-use tools that support whole-animal bioluminescent imaging studies.
Animal models have a long history as essential components in cancer research; however, the application of these models is often limited by the techniques used for evaluating tumor growth and burden. In recent years, the use of BLI in translational research has substantially increased as this technology enables the visualization of in vivo biological events, reduces the number of experimental animals, allows for continual monitoring/imaging of a single individual animal, and decreases the amount of interanimal variation. To support the use of this technology, ATCC has created an expanding portfolio of reporter cancer cell lines that express high levels of firefly luciferase. These advanced models provide a relatively simple, robust, and highly sensitive means to measure biological processes and assess drug efficacy in animal models through bioluminescence imaging, thereby successfully bridging the gap between in vitro and in vivo research.
Jung J. Human tumor xenograft models for preclinical assessment of anticancer drug development. Toxicol Res 30(1): 1-5, 2014.
Jensen MM, et al. Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper. BMC Med Imaging 8: 16, 2008.
Koo V, Hamilton PW, Williamson K. Non-invasive in vivo imaging in small animal research. Cell Oncol 28(4): 129-139, 2006.
Close DM, et al. In vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animals. Sensors (Basel) 11(1): 180-206, 2011.
Zinn KR, et al. Noninvasive bioluminescence imaging in small animals. ILAR J 49(1): 103-115, 2008.
Choy G, et al. Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging. Biotechniques 35(5): 1028-1030, 2003.


The New Forest Complex Systems Conference 2018, will be held from 14 May to 16 May 2018.
The location of the Conference is preferred as Balmer Lawn Hotel in New Forest, UK.
Complex Systems 2018 is an annual Conference.


text:
Q: Howto run a raw-disk Virtualbox VM when using UEFI I have a dual-boot setup on my computer with Windows 10 and Linux (Arch, if relevant).  I'm trying to virtualize my on-disk Linux install in Windows (and plan on doing the opposite direction once I get this way to work).  I've successfully made a raw disk; I just can't boot from it.
I can't seem to access my kernel in my EFI System Partition. My question is, how can I access my EFI System Partition in Virtualbox so I can boot from it?  Should I give up on this approach and do something entirely different?
Thanks for any assistance you are able to provide!

A: You need to make sure the "Enable EFI" option is checked in the machine settings under the System menu.
Screenshot

redpajama_set_name: RedPajamaStackExchange


text:
Inferno (2016)
Inferno (in Hollywood Movies)
Inferno (2016) - Download Movie for mobile in best quality 3gp and mp4 format. Also stream Inferno on your mobile, tablets and ipads
Plot: When Robert Langdon wakes up in an Italian hospital with amnesia, he teams up with Dr. Sienna Brooks, and together they must race across Europe against the clock to foil a deadly global plot.
Runtime: 121 mins
Release Date: 28 Oct 2016
Starcast: Tom Hanks, Felicity Jones, Irrfan Khan
Director(s): Ron Howard
Genre: Action, Adventure, Crime,
Tags: amnesia, church, museum, police, virus
IMDb: http://www.imdb.com/title/tt3062096/
Downloads: 77592.5
IMDb Rating: 6.2/10 (137806 votes)
Inferno BluRay 480p.mp4
(325 MB) { 51548 hits } - MediaInfo - SS
Inferno BluRay 720p.mkv
Inferno, just not bright enough (by jordanando)
For what was meant to be another smash hit in the franchise, Inferno certainly did not live up to expectations. The main reason behind this was the length of the movie, too much was crammed into such a short amount of time that it just wasn't possible to visually create as good a story on film as was in the book. Everything was not explained clear enough in the movie, take that extra half an hour to do that, just to give people an ending they deserve to see. The whole love interest between Elizabeth Sinskey and Langdon just wasn't needed, Langdon is meant to be a guy who only worries <more>
about his work and not women. The love interest however between Sienna and Bertrand was exaggerated in the movie and Howard spent too much screen time on focusing on the pair. In terms of character development it is easy to see why these two plot points were focused on in the movie.As a book, inferno was a hit, as a movie, inferno was dull. There was too much anticipating what was going to happen next because it was straight forward. In the book the characters are much more intriguing and delicately constructed, leaving out Ferris was a major mistake for the movie, this kind of character would have been able to explain a lot of unanswered questions in the movie but would have meant the ending would have to have been the same from the book which cinematically would've been amazing if they worked it out.The scene where Sienna leaves Robert killed the whole suspense about Sienna's real identity and at a moment where the movie could have possibly been saved, it just had nothing.For those that would rather watch a movie than read the book, yeah sure Inferno is a good movie to watch but to the book lovers, this movie was just not the movie we expected from the book. But the score from Zimmer is possibly the best in the series and makes up for the lack of visual engagement in parts.Another problem that persists in adapting books to movies is the question of length, what to leave out and what to include. I think now is the time for the movie industry to say yes we can make a 3-3 1/2 hour movie because leaving out key plot points and character details is just disappointing to the book fans. I don't know if this film warrants doing another one in the series, but if they were to do that, 2 things must be done: 1. make sure it is the original story on screen and 2. make sure the gap isn't seven years. If we get an Origin movie, it needs to have a cast as simple as the Da Vinci Code. Not quite so big, but big enough.A seven out of ten for this movie is reasonable based on the fact it may be visually appealing to someone who hasn't read the book before, to someone who has read the book, this movie probably rings more of a 3-5.
Absolutely brilliant movie! (by arvindvaidyanathan)
This is one of the best movies that I have seen in my entire life! The book of course was fantastic, but unbelievable, the movie is even better! The screenplay is excellent, keeping you engrossed for every single second of the movie. The story of course is brilliant. And the way they have fitted everything into 2 hours is pure genius! Tom Hanks of course is his very best and one has come to expect nothing less from him, probably the greatest actor of all time. All the other actors have done a great job as well. And technically no issues with this film- some beautiful shots of various cities <more>
here! A film everyone must watch, and one that deserves many, many Oscars!
I love Dan Brown movies (by alicecross2000)
Inferno is a wonderful movie I watch for the thrill of the adventure and learning about the characters. I love the twists and turns through out and have loved the Da Vinci Code and Angle and Demons. I am 18 and have always enjoyed Ron Howard and Dan Brown movies and love the Da Vinci Code the best but inferno is amazing and I will always rewatch them.I don't see the bad in this movie I loved the adventure I went on when I watched and I recommend all the Robert Langdon movies to people who appreciate the hard work the went through to make this film . And the art is what I love and how they <more>
combine a thriller story with artists and there artwork.
If you adored the last two, I don't think you'll be as disappointed as the critics would have you believe. (by Madph125)
Honestly, I am not sure where all of the criticism is coming from. It's a thoroughly enjoyable thriller, with constant plot twists riddled through it. It's very similar to both Angels and Demons, and The Davinci Code, so if you considered those mediocre or dull, then expect nothing different here. Many of the critics, it would appear, hated the clue-hunting, historical side of the film. So those critics were, once more, disappointed with the clue-hunting and historical aspects of the film. However, if you saw the first two films and loved them like I do, then you won't be <more>
disappointed, as personally, I believe that this actually brings a lot more to the table.Either way, if you liked the first two, but are concerned about what the critics have to say regarding Inferno, take a look at the reviews for the last two films before you write this film off. The reviews are overly harsh, and many people find the historical fiction and puzzle-solving dull, which if you do, would make the film unbearable. If you don't hate those aspects, then the film is the cherry on top for this trilogy.
I loved every second of the film (by shenchaojie)
First off, i just want to say i have not had the chance to read the book yet but after seeing this film, I am desperate to give it a read. This movie starts off strong with a chase sequence and the explanation of the villain's motives. Then we get to the usual Dan Brown-esque puzzle solving, this time however, it was a bit different to the previous films, he wake up with a bullet wound and memory loss, the first hour of the film revolves around re- connecting all the dots and solve the puzzle he already solved. I wont get into any more spoilers as i want you to enjoy the movie as much as <more>
i did. One thing i would say though is the climax of the movie was done even better than i expected.Also the soundtrack, Hans Zimmer's score for this film was a little bit weaker than the previous two but still absolutely fantastic. Only thing i would say is a bit sub par was the lack of puzzle solving and Christian mythologies which i loved in the previous movies but still, to me this movie was a 9/10 without a doubt.
the best Dan Brown novel adaptation to date - and one of the best thrillers of the year (by dave-mcclain)
This guy has had quite a run! Oh, I'm not talking about Dan Brown, best-selling author of "The Da Vinci Code", or Tom Hanks, the Oscar-winning actor who plays Brown's most famous character, Harvard symbologist Robert Langdon, in the big screen adaptations of Brown's novels, or even Oscar-winner Ron Howard, who has thrice directed Hanks in the role of Langdon. No, as great as those men's careers are, all of their longevity in their fields and cultural influence combined can't touch the significance of the medieval Italian poet known as Dante Alighieri. This man <more>
invented a new kind of poetry, new forms of rhyme and, most importantly, rather than writing in the traditionally used Latin, he wrote in his native Florentine dialect, which was carried by the popularity of his poetry throughout Italy and became the basis for modern Italian. Dante's most famous work, the epic poem popularized under the title "Divine Comedy" in classical literature, "comedy" meaning writing aimed at ordinary people and featuring a happy ending tells the story of Dante making a journey through multiple layers of hell, purgatory and heaven. In doing so, Dante provided an invaluable historical document by depicting real people of his time and telling us what he thought of them based on where they appear in his story , he illustrated the journey of a soul from sin to God's grace and his descriptions of various locations in the afterlife did more to establish our modern images of those places than any other literary work except maybe the Bible. With a backstory like that, it's no wonder that Dan Brown filled his 2013 novel with Dante lore and symbolism, or that Imagine Entertainment and Columbia Pictures chose to give that book the big screen treatment ahead of other previously-published Brown novels. The result is "Inferno" PG-13, 2:01 .Before solving any Dante mysteries in "Inferno", Langdon Hanks has to start by trying to unravel the peculiar and dangerous circumstances of his own life over the previous 2-3 days. Thinking that he's still in Cambridge, Massachusetts, he wakes up in a hospital in Florence, Italy. He has no memory of how he got to Florence, why he's there or what happened to give him his nasty head wound, which the ER doctor, Dr. Sienna Brooks Oscar nominee Felicity Jones , tells him came from being grazed by a bullet! Oh, and he's having vivid and frightening visions of an Armageddon-like future for the human race. When a determined-looking Italian police officer Ana Ularu walks down the hallway to Langdon's room Terminator-style! and starts shooting, Sienna helps Langdon escape and takes him to her apartment. After getting a little sleep, taking a shower and putting on some fresh clothes, Langdon discovers that he has a metal tube with a biohazard symbol on it, only deepening the mystery of what he's involved with.It seems that an American billionaire named Bertrand Zobrist Ben Foster is so worried about the world's increasingly urgent overpopulation problem that he has taken it upon himself to create a deadly new virus and arrange for it to be released in order to "thin the heard" worldwide. The imagery of such a plague brings to mind the first section of Dante's "Divine Comedy", which Dante called "Inferno", and Zobrist hides clues to the location of the virus in Dante-related imagery, in case "something happens" to him and one of his followers needs to execute his plan. When Zobrist dies suddenly, Langdon seems to be just the man to follow the clues and try to stop the virus from being released… if his memory both long and short term turns out to be up to the challenge. With much-needed help from Sienna, Langdon has to rush from Florence to Venice to Istanbul, while being pursued by World Health Organization leaders such as Elizabeth Sinskey Sidse Babett Knudson and Christoph Bouchard Omar Sy – who may or may not be on the same team – as well as ruthless agents of a mysterious security firm headed by Harry Sims Irrfan Khan – and that very angry and determined female member of the Italian Carabineri."Inferno" is the best of the first three Dan Brown novel adaptations and one of the best thrillers of 2016. The stakes are higher, the danger feels more real and the story is better constructed than the previous two Brown films. A number of details have been changed from the book to the movie, but almost all of them seem like positive changes which make this film about as exciting as it can be – propelled with a great use of history and current issues, giving the viewer a lot to learn during the movie and a lot to think about afterward. The plot is very intricate, but so well laid out that it isn't hard to follow and, unlike many thrillers, in the end, everything makes sense and fits together perfectly. In fact, once all of the movie's many surprises have been revealed, you may well want to go back and see it again, just so you can catch all the clues you probably missed the first time. Although I liked this film's predecessors, today, I remember very little of "The Da Vinci Code" and not much more from "Angels & Demons", but "Inferno" is seared into my mind and I think that it's going to stay there for a long time to come. "A"
A masterpiece! Join Prof. Langdon in this Infernally entertaining and fiery-shivering adventure! (by Yelitza-screenwriting-student)
I've seen this film five times already! Now I like it even more, so I'm scoring it a 9! The more I watch it the more I'm convinced of the quality and value of this film. Each time more exciting and enthralling--a joy to watch. Now I care so much about my characters,and I'm with them in their challenges and dilemmas! I'm all Tom-Hanked! Highly stimulating and entertaining. Deliciously complex! Ron's directing weaved the story with fast-paced,multilayered scenes; a web of intrigue and mystery. Got my neurons working at full throttle! And of course the journey is <more>
wonderful: Florence, Venice, Istanbul, just great. Palazzo Vecchio, Il Duomo, Boboli Gardens, Hagia Sophia, etc.--all so culturally enriching!The wonderful: The sequences overflow with beauty, energy and the cinematic experience is supreme! Loved the acting of everyone. All the actors put their heart and soul and were convincing. Tom-Hank's presence brings the whole milieu of mysteries together. He's the central heart of the story. Dr. Sienna Brooks plays an ambiguous role very well, I had no idea she and Zobrist had done the plague-bioengineering together! Jon Donahue's character brought reassurance and balance to the scenes with Langdon and Elizabeth. Professor Langdon is the everyman with a great sensitivity to see patterns and connect the dots—he's a victim and he's the hero here. Great! Loved that! I also loved the sense of constant suspense and ambiguity in the situations. It had me guessing, getting it wrong, and being surprised. Basically Langdon gets kidnapped to serve a purpose: to connect the clues and find the bioengineered plague. But the organization The Provost that kidnaps Langdon has a directive to kill him when he's no longer required, until a truth about Zobrist, the "client" of the Provost, is discovered through a video recording Zobrist left. Langdon is caught in this whirlwind between fake and reality: Dr. Brooks is not who he thinks she is, he even becomes suspicious of Elizabeth. At one point, everyone could be a bad guy, or everyone could be a good guy!! A huge puzzle! At midpoint things go upside down. Dr. Brooks reveals her true self, and Langdon finds new support from WHO World Health Organization and the Provost. After midpoint a lot of truths were revealed, we needed that exposition to clarify our thoughts. Good!Emotional thread: Finding the virus is the goal of the story. Some emotional desires of the characters are revealed after the midpoint, but i wish that had been a bit stronger and earlier in the story. The emotional story is for Langdon to discover if he and Elizabeth can be one again, but this part of the story got a bit diluted—nonetheless it left some lose strings as to imagine that something could happen in the future! Dr. Brooks is in love, but she has been brainwashed by Zobrist, and she will carry out his will, no matter what. Kind of like a Romeo and Juliet tragic romance between these two characters. A long flashback at midpoint will reveal this truth between Sienna and Z. The to-think-about-it: Great message! In the end, the plague and destruction in the name of salvation failed. Good! Humanity doesn't need more apocalyptical menaces. Humanity needs hope and see the light at the end of the tunnel I'll write a screenplay like this smile . Being a genius brings responsibilities—nice message here too. The whole concept of Dante's mask makes me wonder about all those mysteries hidden in so many artifacts and paintings in museums around the world… Each with a story to tell… Exciting. The weird/discordant: Sometimes the hallucinations made sense as such, but when Langdon was seeing the future or events of the past, that was more like psychic abilities. Did the injection give Professor Langdon psychic abilities/ His visions showed the future. That's not possible: a chemical cannot induce visions of the future… Unless the story implies that Professor Langdon is developing psychic abilities? That would be possible, but we would need some hint of that. Same thing happened with the painting – Professor Langdon's mind traveled back in time and saw the flag with the message… I was confused at a climatic point--if Sienna knew about the connections in Istanbul, then she knew that the virus was there? Was she trying to distract Langdon and avoid the WHO to get him? There are some loose strings here. You decide!Screenplay engineering: The director's execution is wonderful, fantastic scenes, the cinematography impeccable, and the acting is great. The problem is the screenplay--some glitches in the logic of events causing some unwanted audience's "What??"'s and "No-Way"'s.The no-no!: Why Sims had to be killed? This cynical man had a sense of humor and intelligence. I wish he had stayed alive and developed a further alliance with WHO and Professor Langdon.Please go and watch this film! Cheers.
The Book is Crazy, The Movie is Better! (by manjodude)
The movie seems to have taken lot of liberties with Dan Brown's book although I cannot compare much since I'm yet to read it fully. I could not go beyond 100 odd pages, it felt very crazy to me. If I were to judge just the movie, I'd say it entertained. I think that's director Ron Howard's skill, he can make any story watchable. There's enough tension to hold our attention till the very end. Although I've heard the book ends differently, I'm glad the movie ends the way it did...felt more sane & positive to me! I find Dan Brown's earlier works like <more>
DaVinci Code or Angels & Demons to be more readable. Technically he may be a great writer but Inferno felt kinda psychotic and I fear what he might come up with next...discourages me to buy any more of his novels.The performances are first rate especially from Irrfan Khan as Sims head of an unscrupulous security company or Ben Foster as the billionaire psychopath Zobrist. Irrfan Khan is almost flawless, but sometimes his gait appears odd. Tom Hanks kinda sleep walks though his role, didn't need to put in much effort to look hassled or worried! Felicity Jones as the smart Dr. Sienna is good.The music is impressive, usually another asset in a Ron Howard movie.It's a good one-time watch. It has just enough drama or action to leave you glued to your seats. Personally I wouldn't recommend it though and that's solely because it's an adaptation of a book that I found to be madness!
Enjoyable for what it is (by facesofine)
I thoroughly enjoyed the movie in spite of a few gripes. The "ER" scene was way too long with too many memory flashes, or hallucinations--which repeated too many times throughout the movie. Not crazy about the romance, or implied romance, between the WHO Director and Langdon. Also, the imagery of a mysterious silver haired lady in my mind from reading the book didn't materialize here, so it was quite a disappointment for me personally. I also wished they had elaborated more on Dante's "Inferno." They also missed the perfect opportunity to showcase the film's <more>
beautiful locations--come on, you're inside St. Marks and the Hagia Sophia, show us more. I love Tom Hanks for being one of the best actors of his day, but I've never liked him in the role of Robert Langdon. Aside from these complaints, the movie was still entertaining and thrilling for what it is, another Dan Brown's Robert Langdon adventure in a 24-hour period. Whether the plot was plausible didn't deter me from enjoying two hours of escaping into the world of Robert Langdon. Unlike other reviewers, I'm fine with the changed ending. It actually provided a nice "twist" to what I was expecting from having read the book.


What to Ask Credit References.
When you have a new client submit a credit application with your business the references are only helpful if you actually use them.
Make certain that your credit application gives you permission to contact references, if not, modify your application to give you permission.
1) How recent was your latest transaction with this firm?
If it wasn't within the last 4 months, the information may not be of great value because your customer's financial position may have changed materially.
2) Are you related to the prospect in any way?
3) Would you consider this firm a good, slow, or bad payer?


text:
In development

## Preview
Using DFS for generation:
![DFS](http://imgur.com/6BATZg5.png)

Using Prim's algorithm for generation:
![Prim's](http://imgur.com/yzJFIzd.png)

redpajama_set_name: RedPajamaGithub


This time of year is known for beautiful fall foliage, apple picking, and Halloween. Many people spend time stocking up on candy, decorations, and maybe even planning a party or scary costume. Take a moment to think about types of popular frightening costumes. What do they have in common?
Some popular Halloween costumes tend to mock types of personalities we are uncomfortable with, including people with mental illness. In fact, even some horror movies take place in psychiatric hospitals or star characters suffering from mental illness. Since it is common for us to fear the unknown and misunderstood, we often attempt to alleviate anxiety by dramatizing or mimicking what we fear. But are these diseases really something to be afraid of?
Halloween costumes that mock mental illness can easily contribute to already existing stigma–a major barrier to treatment. Stigma surrounding mental health disorders is so strong that nearly two-thirds of people affected by them live in silence and go without treatment.
All mental health disorders can seem strange and frightening. Without education and understanding, conditions such as depression, anxiety, PTSD, and bipolar disorder can feel scary. The reality is, millions of Americans struggle with these common illnesses. The good news is, they are treatable.
While October is a time for trick-or-treats, it is also Depression Awareness Month. Contribute to mental health awareness instead of stigma by choosing a costume wisely. Mental illness should viewed like any other illness and treated with dignity, not as a joke.


What has been your career progression thus far? I started out training under a sales team who helped me learn the basics of the job. When my mentor moved to another position, I took over his role and book of business. Based on SoftwareONE's training, I helped my outside reps hit over $1,000,000 in profit each year with the company. Recently, I've been helping with training in our Waukesha, Dallas, and Madrid offices.
Here is James posing with SoftwareONE's Spain team in Madrid!
Favorite part about working at SWO: Our management is very down to Earth – They sit among their teams instead of tucked away into corner offices, and they genuinely appreciate feedback. The managers are always open to change when my team finds a more efficient, more productive, or more fun way to do our jobs. I was looking for a job where I could meet new people and travel to new places. Management understood that and helped me go to Puerto Rico, Las Vegas, Atlanta, Dallas, & Spain all for work.
Biggest challenge you've faced at SWO: The industry is always changing. I'm the kind of person who loves trying new foods, new languages, new places… but the changes can be exhausting if you're not used to them.
What is a typical day like for you?: I grab some free fruit and juice right when I come in the office and hop on a call with my outside reps to prep for the day. Then my day could go in a million directions – Today I was on a call today with employees from Spain, Argentina, Mexico and Peru. Other days are all about getting creative on customer proposals.
What activities do you enjoy in your spare time? Going to concerts, camping, and people watching.
James & some of his favorite co-workers at the 2015 National Sales Kickoff in Milwaukee, WI.
Where do you see yourself in 5 years? I want to move and grow with the company. We have so many locations and different roles today that didn't exist when I started, so I see myself in a completely new position in 5 years.
Advice to people interested in a SWO Career: Interviewing with any company gives you a very limited view of the culture. Come check us out at career fairs, get to know us outside of the interview process, email or LinkedIn message one of us to really see if it's a good fit.
Want to see the world with SoftwareONE? Visit SWO Career Page to start your adventure!


text:
<?xml version="1.0" encoding="UTF-8"?>
<project xmlns="http://maven.apache.org/POM/4.0.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://maven.apache.org/POM/4.0.0 http://maven.apache.org/maven-v4_0_0.xsd">

  <!-- ==================================================================== -->
  <!-- Build requires Java SE 8 or later -->
  <!-- Releases require Java SE 11 or later -->
  <!-- ==================================================================== -->
  <modelVersion>4.0.0</modelVersion>
  <groupId>org.threeten</groupId>
  <artifactId>threetenbp</artifactId>
  <packaging>jar</packaging>
  <name>ThreeTen backport</name>
  <version>1.6.5-SNAPSHOT</version>
  <description>Backport of JSR-310 from JDK 8 to JDK 7 and JDK 6. NOT an implementation of the JSR.</description>
  <url>https://www.threeten.org/threetenbp</url>

  <!-- ==================================================================== -->
  <issueManagement>
    <system>GitHub</system>
    <url>https://github.com/ThreeTen/threetenbp/issues</url>
  </issueManagement>
  <inceptionYear>2007</inceptionYear>

  <!-- ==================================================================== -->
  <developers>
    <developer>
      <id>jodastephen</id>
      <name>Stephen Colebourne</name>
      <roles>
        <role>Project Lead</role>
      </roles>
      <timezone>0</timezone>
      <url>https://github.com/jodastephen</url>
    </developer>
  </developers>
  <contributors>
    <contributor>
      <name>Martin Baker</name>
      <url>https://github.com/kemokid</url>
    </contributor>
    <contributor>
      <name>Graham Borland</name>
      <url>https://github.com/GrahamBorland</url>
    </contributor>
    <contributor>
      <name>Keith Harris</name>
      <url>https://github.com/keithharris</url>
    </contributor>
    <contributor>
      <name>Ludovic Hochet</name>
      <url>https://github.com/lhochet</url>
    </contributor>
    <contributor>
      <name>Tomislav Hofman</name>
      <url>https://github.com/tomislavhofman</url>
    </contributor>
    <contributor>
      <name>Matias Irland</name>
      <url>https://github.com/matir91</url>
    </contributor>
    <contributor>
      <name>David van Leusen</name>
      <url>https://github.com/Kiskae</url>
    </contributor>
    <contributor>
      <name>Eric Li</name>
      <url>https://github.com/ericksli</url>
    </contributor>
    <contributor>
      <name>Pap Lorinc</name>
      <url>https://github.com/paplorinc</url>
    </contributor>
    <contributor>
      <name>Philippe Marschall</name>
      <url>https://github.com/marschall</url>
    </contributor>
    <contributor>
      <name>Michael Nascimento Santos</name>
      <url>https://github.com/sjmisterm</url>
    </contributor>
    <contributor>
      <name>Björn Raupach</name>
      <url>https://github.com/raupachz</url>
    </contributor>
    <contributor>
      <name>Roger Riggs</name>
      <url>https://github.com/RogerRiggs</url>
    </contributor>
    <contributor>
      <name>Siebe Schaap</name>
      <url>https://github.com/sschaap</url>
    </contributor>
    <contributor>
      <name>Sherman Shen</name>
    </contributor>
    <contributor>
      <name>Stanislav Spiridonov</name>
      <url>https://github.com/foal</url>
    </contributor>
    <contributor>
      <name>Philipp Thuerwaechter</name>
      <url>https://github.com/pithu</url>
    </contributor>
    <contributor>
      <name>Andrey Turbanov</name>
      <url>https://github.com/turbanoff</url>
    </contributor>
    <contributor>
      <name> Jake Wharton</name>
      <url>https://github.com/JakeWharton</url>
    </contributor>
  </contributors>

  <!-- ==================================================================== -->
  <licenses>
    <license>
      <name>BSD-3-Clause</name>
      <url>https://raw.githubusercontent.com/ThreeTen/threetenbp/main/LICENSE.txt</url>
      <distribution>repo</distribution>
    </license>
  </licenses>
  <scm>
    <connection>scm:git:https://github.com/ThreeTen/threetenbp.git</connection>
    <developerConnection>scm:git:https://github.com/ThreeTen/threetenbp.git</developerConnection>
    <url>https://github.com/ThreeTen/threetenbp</url>
    <tag>HEAD</tag>
  </scm>
  <organization>
    <name>ThreeTen.org</name>
    <url>https://www.threeten.org</url>
  </organization>

  <!-- ==================================================================== -->
  <build>
    <resources>
      <resource>
        <directory>src/main/resources</directory>
      </resource>
      <resource>
        <targetPath>META-INF</targetPath>
        <directory>${project.basedir}</directory>
        <includes>
          <include>LICENSE.txt</include>
        </includes>
      </resource>
    </resources>
    <!-- define build -->
    <plugins>
      <!-- Enforce Maven 3.5.0 -->
      <plugin>
        <groupId>org.apache.maven.plugins</groupId>
        <artifactId>maven-enforcer-plugin</artifactId>
        <executions>
          <execution>
            <id>enforce-maven</id>
            <goals>
              <goal>enforce</goal>
            </goals>
            <configuration>
              <rules>
                <requireMavenVersion>
                  <version>3.5.0</version>
                </requireMavenVersion>
              </rules>
            </configuration>
          </execution>
        </executions>
      </plugin>
      <!-- Setup testing -->
      <plugin>
        <groupId>org.apache.maven.plugins</groupId>
        <artifactId>maven-surefire-plugin</artifactId>
        <configuration>
          <includes>
            <include>**/Test*.java</include>
          </includes>
          <argLine>-Xmx2G</argLine>
          <parallel>classes</parallel>
          <threadCount>1</threadCount>
          <!-- remove slow SuiteHTMLReporter -->
          <properties>
            <property>
              <name>usedefaultlisteners</name>
              <value>false</value>
            </property>
            <property>
              <name>listener</name>
              <value>org.testng.reporters.ExitCodeListener</value>
            </property>
            <property>
              <name>reporter</name>
              <value>org.testng.reporters.JUnitReportReporter</value>
            </property>
          </properties>
        </configuration>
      </plugin>
      <!-- Setup OSGi bundle data -->
      <plugin>
        <groupId>org.apache.felix</groupId>
        <artifactId>maven-bundle-plugin</artifactId>
        <version>${maven-bundle-plugin.version}</version>
        <executions>
          <execution>
            <id>bundle-manifest</id>
            <phase>process-classes</phase>
            <goals>
              <goal>manifest</goal>
            </goals>
            <configuration>
              <instructions>
                <Import-Package>!sun.util.calendar,*</Import-Package>
                <Require-Capability>osgi.ee;filter:="(&(osgi.ee=JavaSE)(version=1.6))"</Require-Capability>
              </instructions>
            </configuration>
          </execution>
        </executions>
      </plugin>
      <!-- Setup Jar file manifest entries -->
      <plugin>
        <groupId>org.apache.maven.plugins</groupId>
        <artifactId>maven-jar-plugin</artifactId>
        <executions>
          <execution>
            <id>default-jar</id>
            <configuration>
              <archive>
                <manifestFile>${project.build.outputDirectory}/META-INF/MANIFEST.MF</manifestFile>
                <manifestEntries>
                  <Time-Zone-Database-Version>${tz.database.version}</Time-Zone-Database-Version>
                  <Automatic-Module-Name>org.threeten.bp</Automatic-Module-Name>
                </manifestEntries>
              </archive>
            </configuration>
          </execution>
          <execution>
            <id>no-tzdb</id>
            <phase>package</phase>
            <goals>
              <goal>jar</goal>
            </goals>
            <configuration>
              <classifier>no-tzdb</classifier>
              <archive>
                <manifestEntries>
                  <Implementation-Title>ThreeTen backport No-TZDB</Implementation-Title>
                </manifestEntries>
              </archive>
              <excludes>
                <exclude>org/threeten/bp/*.dat</exclude>
                <exclude>org/threeten/bp/zone/TzdbZoneRulesCompiler*</exclude>
                <exclude>META-INF/services/org.threeten.bp.zone.ZoneRulesProvider</exclude>
              </excludes>
            </configuration>
          </execution>
        </executions>
        <configuration>
          <archive>
            <manifest>
              <addDefaultImplementationEntries>true</addDefaultImplementationEntries>
              <addDefaultSpecificationEntries>true</addDefaultSpecificationEntries>
            </manifest>
          </archive>
        </configuration>
      </plugin>
      <!-- Setup Javadoc jar -->
      <plugin>
        <groupId>org.apache.maven.plugins</groupId>
        <artifactId>maven-javadoc-plugin</artifactId>
        <configuration>
          <groups>
            <group>
              <title>ThreeTen</title>
              <packages>org.threeten.bp:org.threeten.bp.chrono:org.threeten.bp.format:org.threeten.bp.temporal:org.threeten.bp.zone</packages>
            </group>
            <group>
              <title>Support classes (do not use)</title>
              <packages>org.threeten.bp.jdk8</packages>
            </group>
          </groups>
        </configuration>
        <executions>
          <execution>
            <id>attach-javadocs</id>
            <phase>package</phase>
            <goals>
              <goal>jar</goal>
            </goals>
          </execution>
        </executions>
      </plugin>
      <!-- Setup source jar -->
      <plugin>
        <groupId>org.apache.maven.plugins</groupId>
        <artifactId>maven-source-plugin</artifactId>
        <configuration>
          <excludeResources>true</excludeResources>
        </configuration>
        <executions>
          <execution>
            <id>attach-sources</id>
            <phase>package</phase>
            <goals>
              <goal>jar-no-fork</goal>
            </goals>
          </execution>
          <execution>
            <id>attach-no-tztb-sources</id>
            <phase>package</phase>
            <goals>
              <goal>jar-no-fork</goal>
            </goals>
            <configuration>
              <classifier>no-tzdb-sources</classifier>
              <excludes>
                <exclude>org/threeten/bp/*.dat</exclude>
                <exclude>org/threeten/bp/zone/TzdbZoneRulesCompiler*</exclude>
                <exclude>META-INF/services/org.threeten.bp.zone.ZoneRulesProvider</exclude>
              </excludes>
            </configuration>
          </execution>
        </executions>
      </plugin>
    </plugins>
    <!-- Manage plugin versions -->
    <pluginManagement>
      <plugins>
        <!-- Maven build and reporting plugins (alphabetical) -->
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-assembly-plugin</artifactId>
          <version>${maven-assembly-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-changes-plugin</artifactId>
          <version>${maven-changes-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-clean-plugin</artifactId>
          <version>${maven-clean-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-compiler-plugin</artifactId>
          <version>${maven-compiler-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-deploy-plugin</artifactId>
          <version>${maven-deploy-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-dependency-plugin</artifactId>
          <version>${maven-dependency-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-enforcer-plugin</artifactId>
          <version>${maven-enforcer-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-gpg-plugin</artifactId>
          <version>${maven-gpg-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-install-plugin</artifactId>
          <version>${maven-install-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-jar-plugin</artifactId>
          <version>${maven-jar-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-javadoc-plugin</artifactId>
          <version>${maven-javadoc-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-jxr-plugin</artifactId>
          <version>${maven-jxr-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-plugin-plugin</artifactId>
          <version>${maven-plugin-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-pmd-plugin</artifactId>
          <version>${maven-pmd-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-project-info-reports-plugin</artifactId>
          <version>${maven-project-info-reports-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-repository-plugin</artifactId>
          <version>${maven-repository-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-resources-plugin</artifactId>
          <version>${maven-resources-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-source-plugin</artifactId>
          <version>${maven-source-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-surefire-plugin</artifactId>
          <version>${maven-surefire-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-surefire-report-plugin</artifactId>
          <version>${maven-surefire-report-plugin.version}</version>
        </plugin>
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-toolchains-plugin</artifactId>
          <version>${maven-toolchains-plugin.version}</version>
        </plugin>
        <!-- Setup release -->
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-release-plugin</artifactId>
          <version>${maven-release-plugin.version}</version>
          <configuration>
            <arguments>-Doss.repo</arguments>
            <autoVersionSubmodules>true</autoVersionSubmodules>
            <tagNameFormat>v@{project.version}</tagNameFormat>
            <localCheckout>true</localCheckout>
          </configuration>
          <dependencies>
            <dependency>
              <groupId>org.kohsuke</groupId>
              <artifactId>github-api</artifactId>
              <version>${github-api.version}</version>
            </dependency>
          </dependencies>
        </plugin>
        <plugin>
          <groupId>org.codehaus.mojo</groupId>
          <artifactId>build-helper-maven-plugin</artifactId>
          <version>${build-helper-maven-plugin.version}</version>
        </plugin>
        <!-- Setup site with reflow maven skin -->
        <plugin>
          <groupId>org.apache.maven.plugins</groupId>
          <artifactId>maven-site-plugin</artifactId>
          <version>${maven-site-plugin.version}</version>
          <configuration>
            <skipDeploy>true</skipDeploy>
          </configuration>
          <dependencies>
            <dependency>
              <groupId>org.joda.external</groupId>
              <artifactId>reflow-velocity-tools</artifactId>
              <version>${reflow-velocity-tools.version}</version>
            </dependency>
          </dependencies>
        </plugin>
        <!-- for Eclipse -->
        <plugin>
          <groupId>org.eclipse.m2e</groupId>
          <artifactId>lifecycle-mapping</artifactId>
          <version>1.0.0</version>
          <configuration>
            <lifecycleMappingMetadata>
              <pluginExecutions>
                <pluginExecution>
                  <pluginExecutionFilter>
                    <groupId>org.apache.felix</groupId>
                    <artifactId>maven-bundle-plugin</artifactId>
                    <versionRange>[2.5.4,)</versionRange>
                    <goals>
                      <goal>manifest</goal>
                    </goals>
                  </pluginExecutionFilter>
                  <action>
                    <ignore />
                  </action>
                </pluginExecution>
              </pluginExecutions>
            </lifecycleMappingMetadata>
          </configuration>
        </plugin>
      </plugins>
    </pluginManagement>
  </build>

  <!-- ==================================================================== -->
  <dependencies>
    <dependency>
      <groupId>org.testng</groupId>
      <artifactId>testng</artifactId>
      <version>6.8.21</version><!-- Later versions need JDK 7 -->
      <scope>test</scope>
      <exclusions>
        <exclusion>
          <groupId>org.beanshell</groupId>
          <artifactId>bsh</artifactId>
        </exclusion>
        <exclusion>
          <groupId>org.yaml</groupId>
          <artifactId>snakeyaml</artifactId>
        </exclusion>
      </exclusions>
    </dependency>
  </dependencies>

  <!-- ==================================================================== -->
  <reporting>
    <plugins>
      <!-- Setup standard project info reports -->
      <plugin>
        <groupId>org.apache.maven.plugins</groupId>
        <artifactId>maven-project-info-reports-plugin</artifactId>
        <version>${maven-project-info-reports-plugin.version}</version>
        <reportSets>
          <reportSet>
            <reports>
              <report>ci-management</report>
              <report>dependencies</report>
              <report>dependency-info</report>
              <report>issue-management</report>
              <report>licenses</report>
              <report>team</report>
              <report>scm</report>
              <report>summary</report>
            </reports>
          </reportSet>
        </reportSets>
      </plugin>
      <!-- Setup Javadoc report -->
      <plugin>
        <groupId>org.apache.maven.plugins</groupId>
        <artifactId>maven-javadoc-plugin</artifactId>
        <version>${maven-javadoc-plugin.version}</version>
        <reportSets>
          <reportSet>
            <reports>
              <report>javadoc</report>
            </reports>
          </reportSet>
        </reportSets>
        <configuration>
          <groups>
            <group>
              <title>ThreeTen</title>
              <packages>org.threeten.bp:org.threeten.bp.chrono:org.threeten.bp.format:org.threeten.bp.temporal:org.threeten.bp.zone</packages>
            </group>
            <group>
              <title>Support classes (do not use)</title>
              <packages>org.threeten.bp.jdk8</packages>
            </group>
          </groups>
        </configuration>
      </plugin>
      <!-- Setup Surefire report -->
      <plugin>
        <groupId>org.apache.maven.plugins</groupId>
        <artifactId>maven-surefire-report-plugin</artifactId>
        <version>${maven-surefire-report-plugin.version}</version>
        <configuration>
          <showSuccess>true</showSuccess>
        </configuration>
      </plugin>
      <!-- Setup changes (release notes) -->
      <plugin>
        <groupId>org.apache.maven.plugins</groupId>
        <artifactId>maven-changes-plugin</artifactId>
        <version>${maven-changes-plugin.version}</version>
        <reportSets>
          <reportSet>
            <reports>
              <report>changes-report</report>
            </reports>
          </reportSet>
        </reportSets>
      </plugin>
    </plugins>
  </reporting>

  <!-- ==================================================================== -->
  <distributionManagement>
    <repository>
      <id>sonatype-threeten-staging</id>
      <name>Sonatype OSS staging repository</name>
      <url>https://oss.sonatype.org/service/local/staging/deploy/maven2/</url>
      <layout>default</layout>
    </repository>
    <snapshotRepository>
      <uniqueVersion>false</uniqueVersion>
      <id>sonatype-threeten-snapshot</id>
      <name>Sonatype OSS snapshot repository</name>
      <url>https://oss.sonatype.org/content/repositories/threeten-snapshots</url>
      <layout>default</layout>
    </snapshotRepository>
    <downloadUrl>https://oss.sonatype.org/content/repositories/threeten-releases</downloadUrl>
  </distributionManagement>

  <!-- ==================================================================== -->
  <profiles>
    <!-- Setup for Java 9+ -->
    <profile>
      <id>java9plus</id>
      <activation>
        <jdk>[9,)</jdk>
      </activation>
      <properties>
        <maven.compiler.release>6</maven.compiler.release>
      </properties>
    </profile>
    <!-- extra javadoc jar file -->
    <profile>
      <id>attach-additional-javadoc</id>
      <activation>
        <property>
          <name>maven.javadoc.skip</name>
          <value>!true</value>
        </property>
      </activation>
      <build>
        <plugins>
          <plugin>
            <groupId>org.codehaus.mojo</groupId>
            <artifactId>build-helper-maven-plugin</artifactId>
            <executions>
              <execution>
                <id>attach-no-tzdb-javadoc</id>
                <phase>package</phase>
                <goals>
                  <goal>attach-artifact</goal>
                </goals>
                <configuration>
                  <artifacts>
                    <artifact>
                      <file>${project.build.directory}/${project.artifactId}-${project.version}-javadoc.jar</file>
                      <type>jar</type>
                      <classifier>no-tzdb-javadoc</classifier>
                    </artifact>
                  </artifacts>
                </configuration>
              </execution>
            </executions>
          </plugin>
        </plugins>
      </build>
    </profile>
    <!-- Deployment profile, activated by -Doss.repo -->
    <profile>
      <id>release-artifacts</id>
      <activation>
        <property>
          <name>oss.repo</name>
        </property>
      </activation>
      <build>
        <plugins>
          <!-- Enforce release is on Java 9 or later -->
          <plugin>
            <groupId>org.apache.maven.plugins</groupId>
            <artifactId>maven-enforcer-plugin</artifactId>
            <executions>
              <execution>
                <id>enforce-java</id>
                <goals>
                  <goal>enforce</goal>
                </goals>
                <configuration>
                  <rules>
                    <requireJavaVersion>
                      <version>[9,)</version>
                    </requireJavaVersion>
                  </rules>
                </configuration>
              </execution>
            </executions>
          </plugin>
          <!-- Sign artifacts -->
          <plugin>
            <groupId>org.apache.maven.plugins</groupId>
            <artifactId>maven-gpg-plugin</artifactId>
            <executions>
              <execution>
                <id>sign-artifacts</id>
                <phase>verify</phase>
                <goals>
                  <goal>sign</goal>
                </goals>
              </execution>
            </executions>
          </plugin>
          <!-- Release to GitHub -->
          <!-- This will create a tag on GitHub on deploy -->
          <!-- The release commit must have been pushed first -->
          <plugin>
            <groupId>de.jutzig</groupId>
            <artifactId>github-release-plugin</artifactId>
            <version>${github-release-plugin.version}</version>
            <configuration>
              <releaseName>Release v${project.version}</releaseName>
              <description>See the [change notes](https://www.threeten.org/threetenbp/changes-report.html) for more information.</description>
              <tag>v${project.version}</tag>
              <overwriteArtifact>true</overwriteArtifact>
            </configuration>
            <executions>
              <execution>
                <id>github-releases</id>
                <phase>deploy</phase>
                <goals>
                  <goal>release</goal>
                </goals>
              </execution>
            </executions>
          </plugin>
          <!-- Use nexus plugin to directly release -->
          <plugin>
            <groupId>org.sonatype.plugins</groupId>
            <artifactId>nexus-staging-maven-plugin</artifactId>
            <version>${nexus-staging-maven-plugin.version}</version>
            <extensions>true</extensions>
            <configuration>
              <nexusUrl>https://oss.sonatype.org/</nexusUrl>
              <serverId>sonatype-joda-staging</serverId>
              <autoReleaseAfterClose>true</autoReleaseAfterClose>
              <keepStagingRepositoryOnCloseRuleFailure>true</keepStagingRepositoryOnCloseRuleFailure>
            </configuration>
          </plugin>
        </plugins>
      </build>
    </profile>
    <profile>
      <id>tzdb-update</id>
      <activation>
        <property>
          <name>tzdb-update</name>
        </property>
      </activation>
      <build>
        <plugins>
          <plugin>
            <groupId>org.codehaus.mojo</groupId>
            <artifactId>exec-maven-plugin</artifactId>
            <version>1.2.1</version>
            <executions>
              <execution>
                <phase>generate-resources</phase>
                <goals>
                  <goal>java</goal>
                </goals>
              </execution>
            </executions>
            <configuration>
              <mainClass>org.threeten.bp.zone.TzdbZoneRulesCompiler</mainClass>
              <classpathScope>compile</classpathScope>
              <arguments>
                <argument>-srcdir</argument>
                <argument>${project.basedir}/src/tzdb</argument>
                <argument>-dstdir</argument>
                <argument>${project.basedir}/src/main/resources/org/threeten/bp</argument>
                <argument>-unpacked</argument>
              </arguments>
            </configuration>
          </plugin>
        </plugins>
      </build>
    </profile>
    <profile>
      <id>tzdb-jar</id>
      <activation>
        <property>
          <name>tzdb-jar</name>
        </property>
      </activation>
      <build>
        <plugins>
          <plugin>
            <groupId>org.codehaus.mojo</groupId>
            <artifactId>exec-maven-plugin</artifactId>
            <version>1.2.1</version>
            <executions>
              <execution>
                <phase>prepare-package</phase>
                <goals>
                  <goal>java</goal>
                </goals>
              </execution>
            </executions>
            <configuration>
              <mainClass>org.threeten.bp.zone.TzdbZoneRulesCompiler</mainClass>
              <classpathScope>compile</classpathScope>
              <arguments>
                <argument>-srcdir</argument>
                <argument>${project.basedir}/src/tzdb</argument>
                <argument>-dstdir</argument>
                <argument>${project.build.directory}</argument>
              </arguments>
            </configuration>
          </plugin>
        </plugins>
      </build>
    </profile>
  </profiles>

  <!-- ==================================================================== -->
  <properties>
    <!-- Plugin version numbers -->
    <build-helper-maven-plugin.version>1.12</build-helper-maven-plugin.version>
    <maven-assembly-plugin.version>3.4.2</maven-assembly-plugin.version>
    <maven-bundle-plugin.version>5.1.8</maven-bundle-plugin.version>
    <maven-changes-plugin.version>2.12.1</maven-changes-plugin.version>
    <!-- v3.0.0 does not work with Eclipse -->
    <maven-checkstyle-plugin.version>2.17</maven-checkstyle-plugin.version>
    <maven-clean-plugin.version>3.2.0</maven-clean-plugin.version>
    <maven-compiler-plugin.version>3.10.1</maven-compiler-plugin.version>
    <maven-deploy-plugin.version>3.0.0</maven-deploy-plugin.version>
    <maven-dependency-plugin.version>3.3.0</maven-dependency-plugin.version>
    <maven-enforcer-plugin.version>3.1.0</maven-enforcer-plugin.version>
    <maven-gpg-plugin.version>3.0.1</maven-gpg-plugin.version>
    <maven-install-plugin.version>3.0.1</maven-install-plugin.version>
    <maven-jar-plugin.version>3.2.2</maven-jar-plugin.version>
    <maven-javadoc-plugin.version>3.4.0</maven-javadoc-plugin.version>
    <maven-jxr-plugin.version>3.2.0</maven-jxr-plugin.version>
    <maven-plugin-plugin.version>3.6.4</maven-plugin-plugin.version>
    <maven-pmd-plugin.version>3.17.0</maven-pmd-plugin.version>
    <maven-project-info-reports-plugin.version>3.4.0</maven-project-info-reports-plugin.version>
    <maven-release-plugin.version>2.5.3</maven-release-plugin.version>
    <maven-repository-plugin.version>2.4</maven-repository-plugin.version>
    <maven-resources-plugin.version>3.3.0</maven-resources-plugin.version>
    <maven-site-plugin.version>3.12.0</maven-site-plugin.version>
    <maven-source-plugin.version>3.2.1</maven-source-plugin.version>
    <maven-surefire-plugin.version>3.0.0-M7</maven-surefire-plugin.version>
    <maven-surefire-report-plugin.version>3.0.0-M7</maven-surefire-report-plugin.version>
    <maven-toolchains-plugin.version>3.1.0</maven-toolchains-plugin.version>
    <!-- Other plugins -->
    <github-api.version>1.307</github-api.version>
    <github-release-plugin.version>1.4.0</github-release-plugin.version>
    <nexus-staging-maven-plugin.version>1.6.13</nexus-staging-maven-plugin.version>
    <reflow-velocity-tools.version>1.2</reflow-velocity-tools.version>
    <!-- Properties for maven-compiler-plugin -->
    <maven.compiler.compilerVersion>1.6</maven.compiler.compilerVersion>
    <maven.compiler.source>1.6</maven.compiler.source>
    <maven.compiler.target>1.6</maven.compiler.target>
    <maven.compiler.fork>true</maven.compiler.fork>
    <!-- Properties for maven-javadoc-plugin -->
    <author>false</author>
    <notimestamp>true</notimestamp>
    <doclint>none</doclint>
    <!-- Other properties -->
    <project.build.sourceEncoding>UTF-8</project.build.sourceEncoding>
    <project.reporting.outputEncoding>UTF-8</project.reporting.outputEncoding>
    <linkXRef>false</linkXRef>
    <tz.database.version>2022fgtz</tz.database.version>
  </properties>
</project>


This spacious one bedroom features a chef inspired kitchen with a breakfast bar, a large living area and an expansive master bedroom with an en suite bathroom giving you direct access to a large walk in closet.
This spacious two bedroom is an entertainers dream! Featuring a chef's island countertop, a large dining and living area and offers 2 large master bedrooms with an en suite bath, featuring large garden tubs, perfect for relaxation.
This two bedroom is the perfect space for entertaining offering a large kitchen with a chef's island, a spacious living area and 2 full size bedrooms featuring en suite baths and spacious walk in closets.
This expansive two bedroom apartment home offers an open floor concept with a spacious kitchen and a large chef's island leading you directly into your living room, and a large corner balcony which offers scenic views of the community, providing you with a perfect place to unwind.
This three bedroom apartment home is a dream, offering a chef inspired kitchen which leads you directly into the living area and to the large private balcony overlooking the gorgeous community. This apartment home also provides you with three large bedrooms featuring walk-in closets in each bedroom.


Conveniently located in Alnwick , BORDER TYRES T/A ALNWICK TYRES is easy to reach from Alnham. Carrying one of the widest ranges of tyre brands and sizes in Alnwick you can book online (pay in store), call us or simply drive in. For your convenience we've provided driving instructions from Alnham to our location in Alnwick .


OLD PARKED CARS.: 1939 MG TB Midget.
Love means never having to put the top on.
I think the Historic plates are kind of silly. Isn't that obvious by looking at it?
i have actually bought "produce" at that quik-e mart. i think it was a banana.
Reminds me that I haven't been to that particular McMenamins in a while.
I KNOW this car.... it's mine! Bought it 39 years ago in Vancouver WA from an ad in The Oregonian (people used to read and place ads in that paper back then). The car had a build date of September 1, 1939, the day Hitler invaded Poland and started WW II. Gas tank is primered red because it was just cut open and cleaned to get the rust out; now it runs smoothly without clogging the gas lines and carbs!
The beauty of the Historic plates in Oregon is that once you pay for them, you never have to re-register every year or every other year..... so there is not annual registration fee!


Im olivia and im 26 years old, i live outside uppsala, with my mum.
I love to be with friends, meet new people, take pictures of everything, bloging, vloging on youtube, love to whatcing tv series and movies ofcourse.
Im a happy, kind, cute and funny girl who like to meet new people.
I love children and play with them and take care of them.
I whatched my friends siters many times before so i have a little experience but i want to learn everything about to be an au apiair.
It was little about me.
I love kids and i love to take care of them and play, and learn new thing and so much other stuff.
Tiene problemas de salud no not at all.


text:
The head of insolvency at one of Ireland's top corporate law firms has warned that recent criticisms of the State's scheme to pay 70 per cent of workers' wages through the sCovid-19 crisis are "without foundation" and risk "social disaster".
Willie Day, head of the restructuring and insolvency practice in Arthur Cox, says anyone who advises SMEs not to sign up to the wage subsidy scheme and lay off staff instead will carry a "heavy responsibility".
Mr Day insisted that fears held by critics who argue that employers declaring they are unable to pay wages could mean them admitting to trading while insolvent, are based on "misunderstandings" of the law.
Under the scheme, the State will pay 70 per cent of wages, capped at €410 per week, if the employers declare that Covid-19 has cut sales by a quarter and they cannot make payroll. The affected workers are then kept on the company's books instead of being laid off.
Some small business groups and the Law Society raised concerns with the Government last week about this provision of the scheme, which was outlined in emergency legislation that passed through the Oireachtas last week.
The Irish Small and Medium Enterprises Association (Isme) warned last week it would have difficulty advising its members to sign up to the scheme for reasons including that the unpaid wages declaration could mean admitting to trading while insolvent. It said the scheme was "tone deaf".
Legal underpinning
Prominent employment lawyer Catherine O'Flynn, who chairs the Law Society's employment committee, also wrote to the Government last Thursday to express "major concern" about the legal underpinning.
"As currently drafted it is unlikely most employers would avail of the provision, and thus the stated aim of the legislation would be stymied," she wrote.
She said the concerns went to the "fundamental operability" of the legislation, although the society stopped short of saying companies should not sign up to it.
Mr Day said "commentators need to be very careful about scaring employers off this scheme", after client companies of Arthur Cox contacted his colleagues in the employment section over the fears.
Mr Day said the notion that you have to declare insolvency to sign up is a "misunderstanding" and the most important thing is not whether or not a company is insolvent, but how it behaves while it is so.
He said directors have to act in the company's interests and that if cash from the State at zero per cent interest was available, as it is under the scheme, then directors ought to sign up for it in the company's best interests.
"If you make such a declaration in good faith based on reasonable evidence, this will be accepted. Revenue has stated explicitly that if they seek to validate employer eligibility for the scheme, they will adopt a reasonable, fair and pragmatic approach in considering whether the criteria have been met."
He said the critics of the scheme had taken a "literal approach" to interpreting the law, which he said "works in hindsight" in terms of validating behaviour.
News by irishtimes.com, edited by Dowling Financial.


text:
An alliance is an informal grouping used in biological taxonomy. The term "alliance" is not a taxonomic rank defined in any of the nomenclature codes. It is used for any group of species, genera or tribes to which authors wish to refer, that have at some time provisionally been considered to be closely related.

The term is often used for a group that authors are studying in further detail in order to refine the complex taxonomy. For example, a molecular phylogenetics study of the Aerides–Vanda Alliance (Orchidaceae: Epidendroideae) confirmed that the group is monophyletic, and clarified which species belong in each of the 14 genera. In other orchid groups, the various alliances that have been defined do not correspond well to clades.

Historically, some 19th century botanical authors used alliance to denote groups that would now be considered orders. This usage is now obsolete, and the ICN (Article 17.2) specifies that such taxa are treated as orders.

See also
Species aggregate
Association (ecology)
Bioindicator

References

Taxa by rank
Botanical nomenclature
Plant taxonomy
Zoological nomenclature

redpajama_set_name: RedPajamaWikipedia


text:
Drunk driver hits Amish buggy, flees the scene
The crash happened around 4:30 Friday evening in Kosciusko County
Remains of the buggy police say Swihart crashed into.(WNDU)
By 16 News Now
Published: Dec. 4, 2021 at 5:35 AM EST
Kosciusko County, Ind. (WNDU) - Police say a drunk driver hit an Amish buggy and fled the crash scene around 4:30 Friday evening.
It happened in the 9600 block of North State Road 19 north of Nappanee. The driver fled to Fulton County.
According to a press release, 30-year-old Kevin Alan Swihart of Akron, was caught after witnesses say he hit the buggy and sped away.
In the buggy was a young girl, whose identity has not been released, and 45-year-old Wayne Hochstetler of Milford.
Hochstetler was treated for injuries at the scene, but his young passenger was taken by helicopter to a nearby hospital.
Deputies tell us she is in stable condition.
Swihart is now in the county jail, facing charges of leaving the scene of a crash, and drunk driving resulting in serious bodily injury.
Copyright 2021 WNDU. All rights reserved.


text:
Graphipterus cordiger is een keversoort uit de familie van de loopkevers (Carabidae). De wetenschappelijke naam van de soort is voor het eerst geldig gepubliceerd in 1831 door Dejean.

cordiger